1375483-13-8

Basic information

• Product Name: carbonic acid tert-butyl ester 2-(4-formylphenoxymethyl)-2,5,7,8-tetramethyl-chroman-6-yl ester
• Synonyms: carbonic acid tert-butyl ester 2-(4-formylphenoxymethyl)-2,5,7,8-tetramethyl-chroman-6-yl ester
• CAS NO: 1375483-13-8
• Molecular Weight: 440.536
• Mol File: 1375483-13-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: carbonic acid tert-butyl ester 2-(4-formylphenoxymethyl)-2,5,7,8-tetramethyl-chroman-6-yl ester(CAS DataBase Reference)
• NIST Chemistry Reference: carbonic acid tert-butyl ester 2-(4-formylphenoxymethyl)-2,5,7,8-tetramethyl-chroman-6-yl ester(1375483-13-8)
• EPA Substance Registry System: carbonic acid tert-butyl ester 2-(4-formylphenoxymethyl)-2,5,7,8-tetramethyl-chroman-6-yl ester(1375483-13-8)

Safety Data

• Hazardous Substances Data: 1375483-13-8(Hazardous Substances Data)

Upstream product

• 53174-07-5 ethyl 6-hydroxy-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromene-2-carboxylate 
• 56305-04-5 trolox 
• 1375483-09-2 6-tert-butoxycarbonyloxy-2,5,7,8-tetramethyl-chroman-2-carboxylic acid ethyl ester 
• 123-08-0 4-hydroxy-benzaldehyde 

Downstream Products

• 1375483-15-0 carbonic acid tert-butyl ester 2-{4-[2,4-dioxo-thiazolidin-(5Z)-ylidenemethyl]phenoxymethyl}-2,5,7,8-tetramethyl-chroman-6-yl ester 

Relevant articles and documents

Synthesis of new troglitazone derivatives: Anti-proliferative activity in breast cancer cell lines and preliminary toxicological study

Breast cancer is the most prevalent cancer in women. The development of resistances to therapeutic agents and the absence of targeted therapy for triple negative breast cancer motivate the search for alternative treatments. With this aim in mind, we synth